Business
Medincell to Present 2024-2025 Annual Results on June 17, 2025
MONTPELLIER, France, June 10, 2025--Regulatory News: Medincell (Paris:MEDCL) will host two live videoconferences on Tuesday, June 17, 2025, to present its financial results for the fiscal year ending March 31, 2025. The results will be published earlier that day following the closing of the Paris stock exchange.
About this update from Medincell Sa
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1772,"height":295,"url":"https://media.zenfs.com/en/business-wire.com/29b8833d2766e6893eeb56ee478c9994"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/rPNNv0ZVGacMG_PY9oOSqg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTE2MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/29b8833d2766e6893eeb56ee478c9994","width":960,"height":160},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/NiwUu0k4aEImVBUgP.G7mQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD00MDA7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/29b8833d2766e6893eeb56ee478c9994","width":1200,"height":200}},"lazy":false},{"type":"text","content":"MONTPELLIER, France, June 10, 2025--(BUSINESS WIRE)--Regulatory News:","length":74,"tagName":"p"},{"type":"text","content":"Medincell (Paris:MEDCL) will host two live videoconferences on Tuesday, June 17, 2025, to present its financial results for the fiscal year ending March 31, 2025. The results will be published earlier that day following the closing of the Paris stock exchange.","length":260,"tagName":"p"},{"type":"text","content":"The presentations will be held in both French and English to accommodate a broad audience of investors, analysts, and stakeholders:","length":131,"tagName":"p"},{"type":"text","content":"French session: 6:00pm CEST / 12:00pm ET> https://www.medincell.com/fr/live-fr/","length":83,"tagName":"p"},{"type":"text","content":"English session: 7:00pm CEST / 1:00pm ET> https://www.medincell.com/live-en/","length":80,"tagName":"p"},{"type":"text","content":"During each session, Medincell’s management team will provide an overview of the company’s performance and strategic outlook and will respond to questions from shareholders. Questions may be submitted in advance via email to [email protected] or asked live during the videoconferences.","length":295,"tagName":"p"},{"type":"text","content":"About Medincell","length":15,"tagName":"p"},{"type":"text","content":"Medincell is a clinical- and commercial-stage biopharmaceutical licensing company developing long-acting injectable drugs in many therapeutic areas. Our innovative treatments aim to guarantee compliance with medical prescriptions, to improve the effectiveness and accessibility of medicines, and to red...